Real-time enrollment status for this grade ii meningioma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT03180268 |
| Recruiting Status | Recruiting |
| Condition | Grade II Meningioma |
| Phase | Clinical Trial |
| Target Enrollment | 163 participants |
| Active Locations | 193 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | January 14, 2026 (Jan 14, 2026) |
As of March 2, 2026: Clinical trial NCT03180268 is currently recruiting participants. This clinical trial study for grade ii meningioma is actively seeking new participants at 193 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03180268 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 193 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03180268 was last updated Jan 14, 2026 (January 14, 2026). HelloStudys verifies this status automatically.